GSK Share Price

Open 1355.00 Change Price %
High 1371.00 1 Day 0.89 0.07
Low 1350.50 1 Week 0.00 0.00
Close 1358.39 1 Month -158.61 -10.46
Volume 10927327 1 Year -176.11 -11.48
52 Week High 1724.50
52 Week Low 1347.00
GSK Important Levels
Resistance 2 1377.39
Resistance 1 1369.56
Pivot 1359.96
Support 1 1347.22
Support 2 1339.39
LON UK Most Active Stocks
CWC 74.60 0.27%
CWC 74.60 0.27%
CWC 74.60 0.27%
INC 0.04 -20.00%
GGP 1.70 -2.86%
GGP 1.70 -2.86%
GGP 1.70 -2.86%
FRR 0.60 7.14%
LLOY 68.74 0.66%
HER 0.04 -20.00%
More..
LON UK Top Gainers Stocks
AKT 28.50 5177.78%
HHR 58.00 900.00%
MLD 10.00 700.00%
HAWK 0.50 100.00%
BAF 72.80 86.67%
BAF 72.80 86.67%
BAF 72.80 86.67%
MES 0.28 75.00%
MES 0.28 75.00%
MES 0.28 75.00%
More..
LON UK Top Losers Stocks
ENDV 0.02 -99.85%
KEA 0.10 -91.30%
ACU 0.05 -87.50%
ACU 0.05 -87.50%
ACU 0.05 -87.50%
DCP 0.50 -75.61%
PCI 3.50 -53.27%
PCI 3.50 -53.27%
BHR 0.02 -33.33%
NBR 0.25 -24.24%
More..

GlaxoSmithKline PLC (LON: GSK)

GSK Technical Analysis 5
As on 1st Nov 2017 GSK Share Price closed @ 1358.39 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1576.40 & Strong Sell for SHORT-TERM with Stoploss of 1489.75 we also expect STOCK to react on Following IMPORTANT LEVELS.
GSK Target for December
1st Target up-side 1464.53
2nd Target up-side 1539.97
3rd Target up-side 1615.42
1st Target down-side 1249.25
2nd Target down-side 1173.81
3rd Target down-side 1098.36
GSK Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.gsk.com
GSK Address
GSK
980 Great West Road
Brentford, TW8 9GS
United Kingdom
Phone: 44 20 8047 5000
GSK Latest News
Interactive Technical Analysis Chart GlaxoSmithKline PLC ( GSK LON UK )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on GlaxoSmithKline PLC
GSK Business Profile
GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, such as vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company provides pharmaceutical products in various therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, antibacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. It also offers consumer health products in total wellness, oral care, nutritional, and skin health areas. The company's total wellness products comprise Panadol for the treatment of headache and joint pain, fever, and cold symptoms; NicoDerm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to quitting smoking; and ENO Tums, a rapid relief antacid. Its oral care products include Sensodyne for the prevention of dental sensitivity; Polident, Poligrip, and Corega to enhance comfort of fitted dentures and to clean dentures; Aquafresh for the prevention of caries, gum disease, and bad breath; and Parodontax to help stop bleeding gums and gum health. The company’s nutrition products comprise Horlicks and Maxinutrition for nutrition; and skin health products include Physiogel, a face and body care product for dry, sensitive, and irritated skin, and Oilatum, a soothing treatment for eczema and dry skin conditions. In addition, it provides prescription medicines; and paediatric and adult vaccines against various infectious diseases. GlaxoSmithKline plc was founded in 1935 and is headquartered in Brentford, the United Kingdom.